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Summary
Fever and generalised lymphadenopathy is a common 
presentation of a variety of diseases and a thorough 
investigation is often necessary for appropriate 
diagnosis.
We present a 53-year-old male patient admitted with 
fever, weight loss of 15 kg in 3 months and abdominal 
discomfort. Examination was only remarkable for 
axillary and inguinal lymphadenopathy. Blood tests 
showed normocytic normochromic anaemia, cholestasis 
and a previously unknown HIV-1 infection with 
lymphocyte CD4 +count of 239 cells/mm3 and viral load 
3.172.370 copies/mL. A body CT scan showed multiple 
axillary, mediastinal, lumbar, aortic, iliac and pelvic 
lymphadenopathy as well as hepatosplenomegaly. An 
excisional biopsy of the left axillary lymphadenopathy 
was performed and histology ultimately revealed 
multicentric Castleman’s disease associated with 
Human Herpes Virus-8. After initiation of antiretroviral 
therapy, rituximab was given and progressive clinical 
improvement occurred.
Background
Fever and generalised lymphadenopathy are 
frequently seen on HIV-positive patients, especially 
those who are unaware of their diagnosis. Because 
the differential diagnosis is broad and variable 
according to the degree of immunosuppression, a 
systematic approach should be taken to achieve a 
proper diagnosis. Infectious diseases including HIV 
infection itself and malignant lymphoid neoplasms 
are the biggest concerns with any patient with this 
presentation. On this clinical case, we illustrate a 
thorough clinical investigation that ended up on a 
rare but treatable entity, making this an educational 
clinical case. This is also a report of a successful 
clinical response of rituximab on this rare clinical 
condition.
caSe preSentation
A 53-year-old male patient, Angolan, currently 
living in a malaria-endemic region of Ethiopia, was 
admitted with fever, asthenia and abdominal pain. 
He had been well 3 months before he developed 
intermittent fever, malaise, anorexia and diffuse 
abdominal pain. He noticed weight loss of 15 kg for 
the last 3 months and referred no other symptoms. 
His personal and familiar history was unremarkable 
and no travelling outside from Ethiopia was noticed 
before his presentation in a Portuguese hospital, 7 
days after travelling from his country.
On examination, he was febrile (38.5°C), blood 
pressure was 110/80 mm Hg, cardiac frequency 90 
bpm, respiratory rate 18 cycles per minute. Lung 
sounds were clear and abdominal examination was 
only remarkable for unpainful hepatosplenomegaly. 
Several axillary and inguinal mobile masses were 
noticed, the largest with 3 cm diameter on left 
axilla, without associated skin findings.
inveStigationS
The admission blood tests results showed normo-
cytic normochromic anaemia (Hg 8,4 g/dL), leuco-
cytosis with lymphocytosis (17.000x109/L and 
9.100x109/L, respectively), platelets 163.000, 
peripheral blood smear was negative for parasites or 
any other abnormalities, C reactive protein 11 mg/
dL and slight elevation of phosphatase alkaline and 
gamma-GT with a normal bilirubin. Protein electro-
phoresis showed a broad-base gamma peak and a 
bone marrow aspirate was performed showing 15% 
plasmocytes with a normal myeloid/erythroid ratio. 
Uroculture, sequential blood cultures, myeloculture 
both for bacteria and mycobacteria, acid fast bacilli 
staining and leishmania direct examination and 
PCR were all negative.
On the first days, haemoglobin decreased to 
6.9 g/dL despite transfusion and brief haemo-
dynamic deterioration occurred. At this time 
there were no clear signs of haemolysis, namely 
increasing lactate dehydrogenase, increasing uncon-
jugated bilirubin or low haptoglobin, and the direct 
Coombs test was also negative. Because blood loss 
was a concern, upper endoscopy and colonoscopy 
were then performed and showed no abnormali-
ties. Laboratory findings were also not consistent 
with adrenal failure and the patient spontaneously 
improved with no further therapy. A body CT scan 
was performed at this time and revealed multiple 
lymphadenopathy: mediastinal, hilar and, lumbar 
and aortic (figure 1).
The patient kept relapsing fever with no other 
complaints. An initially ordered fourth-generation 
HIV test was positive, which was later confirmed 
with positive western blot for HIV-1 infection. 
Lymphocyte T CD4 +count was 239 cells/mm3 and 
viral load was 3.172.370 copies/mL.
Venereal Disease Research Laboratory (VDRL), 
Epstein Barr virus (EBV), cytomegalovirus (CMV), 
toxoplasmosis, hepatitis B virus (HBV) and hepatitis 
C virus (HCV) serology were all negative for recent 
infection.
A surgical biopsy was then performed on the 
left axillary nodal conglomerate which ultimately 
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showed a various lymphatic nodes with preserved nodal structure 
and involution of the germinal centres, interfollicular regions 
filled with plasmocytes and proliferating vascular growth. In 
some of the germinal centres and mantle zones, isolated and 
aggregated plasmablasts could be seen, expressing human herpes 
virus-8 (HHV-8), monotypical for lambda light chains. The 
remaining interfollicular plasmocytes were polyclonal. This find-
ings were consistent with HHV-8-positive variant of multicentric 
Castleman's disease (MCD) (figure 2).
differential diagnoSiS
Most of the series of generalised lymphadenopathy on HIV-pos-
itive patients come from the pre-antiretroviral therapy (ART)
era or from countries where tuberculosis is endemic, making 
mycobacterial infections the first cause of generalised lymph-
adenopathy on this population.1 Because this patient came from 
Ethiopia, a country where tuberculosis is still endemic, this diag-
nosis must be ruled out. Tuberculous lymphadenitis is the most 
common extrapulmonary presentation of Mycobacterium tuber-
culosis infection and tends to occur inversely to CD4 +lympho-
cyte count. Cervical lymph nodes are the most common site and 
in 35% of patients multiple localisations are involved.2
Other Mycobacteria species infections could also have similar 
presentations. Mycobacterium avium complex infections are 
frequently associated with severe anaemia; however, generalised 
lymphadenopathy is less frequent and one should expect a lower 
lymphocyte CD4 +count (eg, <50 cells/uL).3
Blood and bone marrow cultures and in this case lymph node 
biopsy would be helpful for the diagnosis of mycobacterial infec-
tions.
HIV infection itself could be responsible for the clinical symp-
toms, either by acute or chronic infection. Acute viral infection 
was not present in this case because a positive western blot 
implies an infection of more than 3 months and also the symp-
tomatology is consistent with a more indolent disease. Chronic 
HIV infection with this degree of immunosuppression could 
account for constitutional symptoms and generalised lymph-
adenopathy; however, this diagnosis should only be made after 
excluding other entities.
The slow onset of the clinical complains makes most bacte-
rial and other acute infections less likely, however, HBV, HCV, 
Epstein-Barr virus (EBV), cytomegalovirus (CMV) and toxo-
plasmosis should be ruled out as they can present with similar 
complaints.
Visceral leishmaniasis could explain this clinical picture, 
specially fever and hepatosplenomegaly. Lymphadenopathies 
are however a rare finding in this entity.4 For proper diagnosis, 
direct visualisation of parasites on bone marrow smear or posi-
tive culture are required.
Lymphoma is always a concern in any patient with lymph-
adenopathy, especially those with HIV infection. Such patients 
have higher risk of developing lymphomas and highly aggressive 
non-Hodgkin lymphomas such as Burkitt lymphoma and diffuse 
B cell are common.5
Classically, the risk of developing lymphoma is proportional to 
the degree of immunosupression with median lymphocyte CD4 
+count 200 cells/mm3 at diagnosis.6 Some types of lymphoma 
are specially related to HIV infection, such as plasmablastic, oral 
cavity, pleural cavity lymphomas and HHV-8 related Kaposi 
sarcoma.7
Differently from HIV-negative patients, lymphomas usually 
present more acutely and on a highly aggressive way on 
HIV-positive patients, being more advanced at diagnosis and 
more frequently with associated B symptoms (ie, fever, weight 
loss and nocturnal sudoresis).8
An uncommon entity that can be easily confounded with a 
lymphoma is MCD, where lymph node histology is essential for 
establishing the correct diagnosis.
treatment
After diagnosis, antiretroviral therapy (ART) was initiated with 
efavirenz, tenofovir and emtricitabine with good tolerance 
and significant improvement of symptoms and anaemia. After 
1 month, rituximab was then initiated (375 mg/m2 weekly during 
4 weeks) and an impressive response was observed on lymph-
adenopathy. Anaemia and weight also improved after four doses 
of this drug and no adverse effects were observed during the 
treatment period.
outcome and follow-up
During the 8-month follow-up period, no adverse effects were 
noticed and symptomatology improved considerably with 
weight gain, haemoglobin improvement and lymphadenopathy 
resolution. After 5 years of follow-up, the patient is alive and 
without any evidence of recurring disease nor evolution into 
lymphoma.
figure 1 Body CT scan showing multiple lymphadenopathy.
figure 2 Lymph node biopsy showing diffuse plasmocyte infiltration 
with positive staining for HHV-8, human herpes virus-8.
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diScuSSion
Castleman’s disease is a heterogeneous group of rare diseases 
which have in common augmented production of interleukin 
6 with lymphoid hyperplasy. Both localised or unicentric and 
multicentric forms exist, being the later more commonly associ-
ated with HHV-8 and also with HIV infection. Annual incidence 
of MCD is 8.3/10.000 patients per year, a number that has raised 
after rising after the introduction of ART.9
Clinical presentation of multicentric disease is usually 
undistinguishable from a lymphoma with generalised lymph-
adenopathy and hepatosplenomegaly. Its pathophysiology is 
still not fully understood; however, HHV-8 plays a role as it 
is commonly found on biopsies.10 Laboratory markers are 
unspecific, presenting commonly with anaemia, thrombocytosis, 
elevated erythrocyte sedimentation rate and hypergammaglobu-
laemia. Histological hallmark includes a polyclonal plasmocitary 
expansion with normal nodal structure and HHV-8 identifica-
tion which is almost always present on HIV-positive patients.11
Although it is a benign histological entity, MCD accounts for 
significant morbidity and mortality, either because of bacterial 
infection predisposition or for the risk of developing associ-
ated malignancies such as Kaposi sarcoma and non-Hodgkin’s 
lymphoma.12 Histology in this patient additionally showed 
increased expression of lambda free light chains, a finding that 
had been suggested to be linked to increased susceptibility to 
developing a high-grade lymphoma.13
Because it is such an uncommon diagnosis, treatment expe-
rience is still sparse and only based on observational studies. In 
HIV-positive patients, treatment with rituximab showed good 
results with an overall low relapse rate and with acceptable 
safety profile.14 Patients with low CD4 +counts and high viral 
loads should start ART before rituximab to decrease viral load. 
Some authors suggest the addition of chemotherapy to ritux-
imab on severe cases including those with end-organ failure; 
however, benefit is still not clear comparing with rituximab 
monotherapy.15
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learning points
 ► Fever and lymphadenopathy is a frequent presentation of 
a variety of diseases and intensive investigation should be 
performed to achieve a proper diagnosis as many important 
and life-threatening conditions can present this way.
 ► HIV infection should be ruled out in these situations 
especially in patients coming from endemic areas.
 ► Differential diagnosis should take in account the level of 
immunosuppression but ultimately many conditions should 
be considered.
 ► Multicentric Castleman’s disease is a rare entity that 
required a histology diagnosis and should be considered in 
patients with HIV with unexplained fever and generalised 
lymphadenopathy.
 ► Treatment of this condition is still not consensual but 
rituximab either on monotherapy or associated with 
chemotherapy has been showing good results.
